Veracyte, Inc.

VCYT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$24-$74-$37-$76
Dep. & Amort.$23$27$26$20
Deferred Tax-$0-$4$0-$6
Stock-Based Comp.$36$33$27$23
Change in WC-$21-$4-$16$4
Other Non-Cash$13$66$8$4
Operating Cash Flow$75$44$8-$32
Investing Activities
PP&E Inv.-$11-$10-$9-$5
Net Acquisitions$5$0$0-$737
Inv. Purchases-$50-$20-$34$162
Inv. Sales/Matur.$0$45$13$3
Other Inv. Act.$0$0$0-$162
Investing Cash Flow-$56$15-$29-$739
Financing Activities
Debt Repay.$0$0-$1$0
Stock Issued$20$0$0$594
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$15$3$5$2
Financing Cash Flow$5$3$3$596
Forex Effect-$0$0-$1-$2
Net Chg. in Cash$23$62-$19-$176
Supplemental Information
Beg. Cash$217$155$174$350
End Cash$241$217$155$174
Free Cash Flow$64$34-$1-$37